Champions Oncology (CSBR) Free Cash Flow Growth (3y) (2013 - 2026)
Champions Oncology (CSBR) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Champions Oncology |
81.79 Mn |
74.79 Mn |
13.89 Mn |
-56.66% |
| Date | Value |
|---|
| Jan 31, 2026 |
-56.66% |
| Oct 31, 2025 |
-38.18% |
| Jul 31, 2025 |
37.22% |
| Apr 30, 2025 |
186.32% |
| Jan 31, 2025 |
-54.87% |
| Oct 31, 2024 |
-34.40% |
| Jul 31, 2024 |
34.81% |
| Apr 30, 2024 |
13.79% |
| Jan 31, 2024 |
45.59% |
| Oct 31, 2023 |
10.99% |
| Jul 31, 2023 |
-48.14% |
| Apr 30, 2023 |
-35.21% |
| Jan 31, 2023 |
96.47% |
| Oct 31, 2022 |
65.94% |
| Jul 31, 2022 |
2.63% |
| Apr 30, 2022 |
35.69% |
| Jan 31, 2022 |
31.45% |
| Oct 31, 2021 |
72.55% |
| Jul 31, 2021 |
-95.99% |
| Apr 30, 2021 |
-140.79% |
